staff met with White House officials and others on Aug. 2 to discuss drug use
and abuse as part of a roundtable discussion hosted by the White House Office
of National Drug Control Policy (ONDCP). In July, ONDCP released an interim
report by President Trump’s Commission on Combating Drug Addiction and the
Opioid Crisis. The
report contains nine policy recommendations aimed at stemming the
nation’s growing opioid crisis, which currently claims more than 100 lives
commission points to overprescribing of opioids in the health care system as a
foundational cause of the crisis and recognizes the role dental schools can
play in enhancing prescriber education. The report calls on the President to
amend the Controlled Substance Act to require all Drug Enforcement
Administration (DEA) registrants to take a course in the proper treatment of
pain and recommends drawing on “the assistance of medical and dental schools
across the country” to enhance prevention through prescriber education.
report recognizes Massachusetts Governor Charlie Baker’s administration for
“work[ing] with the medical and dental schools in that state and the Medical
Society to develop core competencies related to opioids and [substance
use disorders] that all graduating students are expected to learn and
put into practice.”
the commission’s other recommendations are:
- Rapidly increase drug treatment capacity.
- Enhance access to medication-assisted treatment.
- Support state legislation to allow naloxone dispensing
via standing orders.
- Prioritize funding to staunch the flow of
synthetic opioids into the United States.
- Enhance interstate data sharing.
- Enforce the Mental Health Parity and Addiction
the meeting, ADEA President and CEO, Dr. Rick Valachovic sent a letter to
ONDCP informing the office that “academic dentistry is equally concerned and
committed to solutions to address the prescription drug and opioid abuse
problem in the United States.”